Orally Disintegrating Tablets - enhancing ease of use and patient compliance
Orally disintegrating tablets (ODT), are an innovative solid oral dosage form that is becoming more and more important in the pharmaceutical market, both for prescription and over-the-counter medications. In contrast to classical tablets, ODTs are specifically designed to disintegrate directly in the patient's mouth. The disintegrated tablet can then be swallowed easily without any resistance. BASF offers a comprehensive set of excipients that help you to easily formulate your active ingredient in an effective ODT.
Tablets that disintegrate quickly in the mouth offer several distinct advantages. They are particularily helpful for pediatric and geriatric patients who have difficulty in swallowing, as well as for patients on the move or where safe drinking water is not readily available. Swallowing difficulty is a frequent complication associated with a number of diseases including stroke, Parkinson's disease and other age-related conditions. Since there is no need to swallow bulky tablets anymore, they can significantly increase patient compliance and thus can be used for higher drug concentration.
BASF's innovative range of excipients is revolutionizing the ease of taking medication while increasing compliance among at-risk groups. Our cutting-edge products help you to easily formulate your active ingredient in an effective ODT.
With our commitment to helping develop new medication while increasing the ease-of-use of existing formulations, BASF is playing a vital role in improving the effectiveness of healthcare worldwide.
Orally disintegrating tablets offer significant advantages in order to overcome certain weaknesses of classical solid oral dosage forms:
- Patient compliance is increased due to ODT superior easy way of administration
- Increased medication compliance among very young and elderly due to
- Suitable for both prescription and over-the-counter drugs
- ODTs are an on-the-go dosage form, which can be taken without water